Exevir Bio BV
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.exevir.com
Clinical Trials
5
Active:3
Completed:1
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- ExeVir Bio BV
- Target Recruit Count
- 27
- Registration Number
- NCT04884295
- Locations
- 🇮🇹
Investigative Site, Roma, Italy
🇲🇩Investigative site, Chisinau, Moldova, Republic of
News
No news found